Merck Says High Court Should Hear 2 Pay-For-Delay Cases
Merck & Co. Inc. on Tuesday renewed its challenge to a Third Circuit ruling holding "pay-for-delay" pharmaceutical patent settlements as presumptively anti-competitive, telling the U.S. Supreme Court that it should take...To view the full article, register now.
Already a subscriber? Click here to view full article